Xencor XNCR
NASDAQ XNCR
$26.60 -0.02 (-0.08%)
As of: Sep 4, 2026 · 1:40 PM EDT

Xencor (XNCR) Income towards Parent Company (2013 - 2026)

Xencor (XNCR) posted quarterly Income towards Parent Company of -$128.9 million for Q1 2026, down 164.95% year-over-year from $198.5 million in Q1 2025, and down 1838.01% quarter-over-quarter from -$6.7 million in Q4 2025.

Analysis

Xencor (XNCR) Income towards Parent Company (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Income towards Parent Company for 14 consecutive years, with -$128.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Income towards Parent Company fell 164.95% year-over-year to -$128.9 million; the TTM figure through Mar 2026 stood at -$172.4 million (up 18.31% YoY), while the FY2025 annual figure was -$92.1 million, up 61.05% from the prior year.
  • Income towards Parent Company declined to -$128.9 million in Q1 2026 per XNCR's latest filing, from -$6.7 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $25.8 million in Q1 2022 and bottomed at -$128.9 million in Q1 2026.
  • Historically, Income towards Parent Company has averaged -$42.2 million across 5 years, with a median of -$46.2 million in 2024.
  • Annual changes were most pronounced in 2022 — Income towards Parent Company jumped 259.43% — and 2023, when it slumped 327.17%.
  • Xencor's Income towards Parent Company stood at -$12.0 million in 2022, then sank by 118.49% to -$26.3 million in 2023, then sank by 75.6% to -$46.2 million in 2024, then soared by 85.6% to -$6.7 million in 2025, then plunged by 1838.01% to -$128.9 million in 2026.
  • Business Quant data shows XNCR's Income towards Parent Company at -$128.9 million in Q1 2026, -$6.7 million in Q4 2025, and -$6.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Xencor 2.02 Bn 1.64 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.72 Mn
Mar 31, 2026 -128.94 Mn
Dec 31, 2025 -6.65 Mn
Sep 30, 2025 -6.03 Mn
Jun 30, 2025 -30.78 Mn
Mar 31, 2025 -48.67 Mn
Dec 31, 2024 -46.20 Mn
Sep 30, 2024 -47.44 Mn
Jun 30, 2024 -68.78 Mn
Mar 31, 2024 -74.12 Mn
Dec 31, 2023 -26.31 Mn
Sep 30, 2023 -24.27 Mn
Jun 30, 2023 -26.00 Mn
Mar 31, 2023 -57.85 Mn
Dec 31, 2022 -12.06 Mn
Sep 30, 2022 -32.77 Mn
Jun 30, 2022 -28.00 Mn
Mar 31, 2022 26.47 Mn
Dec 31, 2021 73.06 Mn
Sep 30, 2021 -40.19 Mn